Sinusoidal obstruction syndrome MRI: Difference between revisions
| Line 9: | Line 9: | ||
==MRI== | ==MRI== | ||
MRI studies with hepatocyte-specific contrast agent show a diffuse hypointense reticular pattern on post-contrast T1 delayed hepatobiliary phase | MRI studies for the diagnosis of sinusoidal obstruction syndrome with hepatocyte-specific contrast agent show a diffuse hypointense reticular pattern on post-contrast T1 delayed hepatobiliary phase.<ref name="pmid28126425">{{cite journal| author=Li X, Yang X, Xu D, Li Q, Kong X, Lu Z et al.| title=Magnetic Resonance Imaging Findings in Patients With Pyrrolizidine Alkaloid-Induced Hepatic Sinusoidal Obstruction Syndrome. | journal=Clin Gastroenterol Hepatol | year= 2017 | volume= 15 | issue= 6 | pages= 955-957 | pmid=28126425 | doi=10.1016/j.cgh.2017.01.009 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28126425 }} </ref> | ||
==References== | ==References== | ||
Revision as of 23:57, 7 February 2018
|
Sinusoidal obstruction syndrome Microchapters |
|
Differentiating Sinusoidal obstruction syndrome from Other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Sinusoidal obstruction syndrome MRI On the Web |
|
American Roentgen Ray Society Images of Sinusoidal obstruction syndrome MRI |
|
Directions to Hospitals Treating Sinusoidal obstruction syndrome |
|
Risk calculators and risk factors for Sinusoidal obstruction syndrome MRI |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
MRI studies for the diagnosis of sinusoidal obstruction syndrome with hepatocyte-specific contrast agent show a diffuse hypointense reticular pattern on post-contrast T1 delayed hepatobiliary phase.
MRI
MRI studies for the diagnosis of sinusoidal obstruction syndrome with hepatocyte-specific contrast agent show a diffuse hypointense reticular pattern on post-contrast T1 delayed hepatobiliary phase.[1]
References
- ↑ Li X, Yang X, Xu D, Li Q, Kong X, Lu Z; et al. (2017). "Magnetic Resonance Imaging Findings in Patients With Pyrrolizidine Alkaloid-Induced Hepatic Sinusoidal Obstruction Syndrome". Clin Gastroenterol Hepatol. 15 (6): 955–957. doi:10.1016/j.cgh.2017.01.009. PMID 28126425.